AORT Form 144 shows Marshall Stanton to sell 47K shares

Rhea-AI Filing Summary

A holder of AORT common stock, Marshall S. Stanton, has filed a Form 144 notice to sell 47,376 shares of common stock through Fidelity Brokerage Services on the NYSE. The issuer has 47,374,939 common shares outstanding, which shows the planned sale is small relative to the total share count.

The shares to be sold were acquired on 11/21/2025 through the exercise of two stock options originally granted on 02/23/2022 and 11/08/2022, paid for in cash. The form also reports recent sales by Stanton over the past three months, including 15,276 shares sold on 11/20/2025 for gross proceeds of $674,833.49.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	47376	2133936.47	47374939	11/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/21/2025	Option Granted 02/23/2022	Issuer			20301	11/21/2025	Cash
Common	11/21/2025	Option Granted 11/08/2022	Issuer			27075	11/21/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Marshall S. Stanton 1655 Roberts Boulevard, NW Kennesaw GA 30144	Common	11/10/2025	2566	114492.10
Marshall S. Stanton 1655 Roberts Boulevard, NW Kennesaw GA 30144	Common	11/13/2025	4993	228970.50
Marshall S. Stanton 1655 Roberts Boulevard, NW Kennesaw GA 30144	Common	11/20/2025	15276	674833.49

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the AORT Form 144 filing disclose?

The Form 144 filing discloses that Marshall S. Stanton plans to sell 47,376 shares of AORT common stock on the NYSE through Fidelity Brokerage Services LLC under Rule 144.

How many AORT shares are planned to be sold under this Form 144?

The notice states that 47,376 common shares of AORT are to be sold, with a reported aggregate market value of $2,133,936.47.

How many AORT shares are outstanding according to the Form 144?

The form reports that there are 47,374,939 AORT common shares outstanding, which provides context for the relative size of the 47,376-share planned sale.

How and when were the AORT shares in this Form 144 acquired?

The filing shows the shares were acquired on 11/21/2025 by exercising two stock options granted on 02/23/2022 and 11/08/2022, with 20,301 and 27,075 shares acquired for cash.

What recent AORT stock sales by the filer are reported in the past three months?

The form lists three recent sales by Marshall S. Stanton: 2,566 shares on 11/10/2025 for $114,492.10, 4,993 shares on 11/13/2025 for $228,970.50, and 15,276 shares on 11/20/2025 for $674,833.49.

What representation does the seller make in the AORT Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, and acknowledges that intentional misstatements or omissions are Federal criminal violations.